Ads
related to: experimental prostate cancer drugs names- Patient Resources
Download informative brochures for
patients and caregivers.
- Find An Imaging Site
Locate the nearest imaging site
or contact customer service.
- Reimbursement Support
The patient support program
can assist insurance assessment.
- Talk To Your Doctor
Review questions to start a
conversation with your doctor.
- Patient Resources
Search results
Results from the WOW.Com Content Network
Experimental cancer treatments are normally available only to people who participate in formal research programs, which are called clinical trials. Occasionally, a seriously ill person may be able to access an experimental drug through an expanded access program. Some of the treatments have regulatory approval for treating other conditions.
Pages in category "Experimental cancer drugs" The following 200 pages are in this category, out of approximately 262 total. This list may not reflect recent changes .
Apalutamide was approved by the Food and Drug Administration in the United States, under the brand name Erleada, for the treatment of non-metastatic castration-resistant prostate cancer in February 2018. [8] [9] It was subsequently approved in Canada, the European Union, and Australia. [42] [6]
Experimental cancer drugs (262 P) D. Drugs with undisclosed chemical structures (42 P) E. Experimental anti-obesity drugs (5 C, 20 P) Experimental antiviral drugs (45 P)
Seviteronel (developmental codes VT-464 and, formerly, INO-464) is an experimental cancer medication which is under development by Viamet Pharmaceuticals and Innocrin Pharmaceuticals for the treatment of prostate cancer and breast cancer. [1]
Zibotentan (INN; development code ZD4054) is an experimental anti-cancer drug candidate in development by AstraZeneca. [1] It is an endothelin receptor antagonist. [2] Zibotentan was granted fast track status for the treatment of prostate cancer by the FDA. It failed a phase III clinical trial for prostate cancer, [3] but other trials are ...
Ads
related to: experimental prostate cancer drugs names